scispace - formally typeset
M

Marco Valgimigli

Researcher at University of Bern

Publications -  772
Citations -  91095

Marco Valgimigli is an academic researcher from University of Bern. The author has contributed to research in topics: Percutaneous coronary intervention & Myocardial infarction. The author has an hindex of 105, co-authored 696 publications receiving 69184 citations. Previous affiliations of Marco Valgimigli include University of Düsseldorf & Erasmus University Medical Center.

Papers
More filters
Journal ArticleDOI

Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients

TL;DR: Several polymorphisms impact clopidogrel response and PgxRS is a predictor of cardiovascular outcomes, and patients who carried a greater number of alleles that associated with increased on-treatment platelet reactivity were more likely to experience CVEs.
Journal ArticleDOI

Genetic determinants of on-clopidogrel high platelet reactivity.

TL;DR: The aim of this review is to describe the principal gene polymorphisms influencing on-clopidogrel PR and their relationship with long-term clinical outcome.
Journal ArticleDOI

Hydroxyl radical generation, levels of tumor necrosis factor-alpha, and progression to heart failure after acute myocardial infarction

TL;DR: A distinct pattern of hydroxyl radical generation is found in post-MI patients who show progression to HF, and the interplay between OSS and inflammatory status should be targeted as a possible mechanism of progression to post- MI left ventricular dysfunction.